The alteration of first trimester screening markers in fresh and frozen-thawed blastocyst transfers
Open Access
- 3 July 2019
- journal article
- Published by The European Research Journal in The European Research Journal
- Vol. 5 (4) , 686-690
Abstract
Objective: The aim of this study was to investigate whether first trimester combined screening for major fetal trisomies is influenced by assisted reproduction techniques (ART) from blastocyst transfer, with or without cryopreservation.Methods: This study is a retrospective analysis involving 115 singleton pregnancies with euploid fetuses recruited between January 2017 and December 2017. Sixty-five women conceived with fresh blastocysts from in vitro fertilization (IVF) cycles (fresh-blasto), 50 with frozen-thawed blastocysts. All cases underwent ultrasound assessment at 11+0 - 13+6 weeks with measurements of crown rump length, nuchal translucency (NT) , free beta-human chorionic gonadotrophin (free β-hCG) and pregnancy-associated plasma protein A (PAPP-A) concentrations.Results: Baseline characteristics and pregnancy outcomes did not differ substantially among the study groups. The NT was not significantly different in the frozen-thawed -blasto compared to the fresh-blasto group (p = 0.741). The free β-hCG levels was not significantly different in frozen-thawed-blasto group compared to fresh-blasto group (p = 0.495). The two groups showed no significant difference in the PAPP-A levels (p = 0.139). The median delta crown rump length was also not significantly different among the two groups (p = 0.758).Conclusions: In ART pregnancies from blastocyst transfer, with or without cryopreservation, the NT measurement, free β-hCG concentration and PAPP-A levels did not show any significant difference. These features are apparently unrelated to the outcome of pregnancy and may be due to alterations or delays in embryogenesis or placentation with potential relevance for the screening test performance.Keywords
This publication has 28 references indexed in Scilit:
- First trimester maternal serum PAPP‐A, β‐hCG and ADAM12 in prediction of small‐for‐gestational‐age fetusesPrenatal Diagnosis, 2008
- First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10–14 weeks of gestationFertility and Sterility, 2008
- Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screeningPrenatal Diagnosis, 2004
- Integrated first‐ and second‐trimester Down syndrome screening test among unaffected IVF pregnanciesPrenatal Diagnosis, 2004
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experienceBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years experienceBJOG: An International Journal of Obstetrics & Gynaecology, 2003
- First-trimester screening for Down’s syndrome in in vitro fertilization pregnanciesFertility and Sterility, 2001
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- Screening of Maternal Serum for Fetal Down's Syndrome in the First TrimesterNew England Journal of Medicine, 1998
- Regulation and Activities of α-FetoproteinCritical Reviews™ in Eukaryotic Gene Expression, 1997